George Sellers
Stock Analyst at Stephens & Co.
(1.32)
# 3,510
Out of 4,911 analysts
43
Total ratings
27.27%
Success rate
-7.21%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $42.52 | +59.92% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $117.19 | +147.46% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $40.12 | +44.57% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $108.00 | +64.81% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $11.55 | +107.88% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $27.54 | +161.44% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.54 | +96.85% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $5.70 | +338.60% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $19.20 | +196.95% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $94.16 | -24.59% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $42.52
Upside: +59.92%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $117.19
Upside: +147.46%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $40.12
Upside: +44.57%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $108.00
Upside: +64.81%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $11.55
Upside: +107.88%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $27.54
Upside: +161.44%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.54
Upside: +96.85%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $5.70
Upside: +338.60%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $19.20
Upside: +196.95%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $94.16
Upside: -24.59%